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This thesis addresses two major topics in measuring, comparing and 
improving quality of care. We found considerable influence of random 
variation and case-mix in comparing hospitals using performance indicators. 
Although we found a significant relation between outcome and care 
processes, chance variation is the major limitation for the interpretability of 
indicators used for quality measurement or quality improvement. Like a one 
hand clock, we roughly know what time it is.
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Voor Pappie, omdat ik nu begrijp wat je me toen vertelde.
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HosPItal Performance and measurement 
The Dutch Quality Act  (1996) provides a  framework  in which health  care providers 
are given responsibility to be transparent on their outcomes of delivered care. The 
essence of  the Quality Act  is  that care providers are held responsible  for providing 
good and affordable  care  and  improvement of  the quality  of  care.  Transparency  is 




































definitions of quality of care










measuring quality of care
Aiming at measuring quality, Donabedian described care as a function of three com-
ponents: structure, process and outcome.[6, 7] The evaluation of structure consists 
in  the appraisal of  the  instrumentalities of care and their subsequent organisation, 
equipment,  manpower  and  financing.  Donabedian  stated:  “If  these  meet  certain 
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General Introduction
captures  the  effect  of  care  processes  on  the  health  and wellbeing  of  patients.  For 
example,  the  occurrence  of  pressure  ulcers  during  hospital  admission  (nosocomial 
pressure ulcers), but also the degree of the patient’s satisfaction with care. Data cap-
turing structure, process, or outcome, are known as performance indicators. 
A performance  indicator, being a  retrospective measurable element of practice  for 
which  there  is evidence or  consensus, provides  insight  in quality of  care.[11,  12] As 





Nowadays  performance  indicators  are  used  for  public  accountability,  for  external 
assessment, for supervision, for purchase, for supporting patient choice, for internal 
management control and for internally driven quality improvement. 
cHallenges to tHe measurement of HosPItal Performance
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meant with  “re-admission”?  Every  readmission  in  this time period or  re-admission 
for  heart  failure  or  unplanned  re-admission?  So,  the  term  readmission  is  far  from 
unambiguous. Defining concepts in a clear and explicit way has been addressed in the 
past decades and needs ongoing attention and adjustments.[9, 13, 14].




































[25]  In  2008,  the  Australian  Health  and  Hospital  reform  Commission  proposed  a 








tific  research,  has  received  little  attention  in  defining  and developing  performance 
indicators.[28] As a result hereof, most differences  found when comparing hospital 
performance  can  be  ascribed  to  random  variation.  Random  variation  stays  often 
unaddressed in reports on performance indicators. For instance, in the Netherlands, 





Figure 1. Pressure ulcer prevalence in 89 Dutch hospitals in 2005[29] 
The x-axis represents 88 Dutch hospitals, with their outcomes displayed on the y-axis. 
Hospitals are ranked by their outcome of pressure ulcer prevalence, ranging in this example 
from ± 2% to almost 20%. This bar chart suggests an almost 17%-points difference in 
pressure ulcer prevalence between the best and the worst performing hospitals. It does 
however, not provide an insight in the statistical uncertainty of these differences. The 
confidence interval for small hospitals has a greater spread compared to the spread of the 
interval in larger hospitals.[30] The risk of 'false positive' results (indicator suggests lack of 
quality, but this does not withstand examination) is considerable, as a result of random 
variation.[15, 31, 32] Statisticians therefore often emphasize addressing random variation in 
reporting performance.[30, 33] It remains unclear in the Netherlands to what extent 
random variation influences between-hospital comparisons with commonly used outcome 
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The confounding effect  that variations  in patient  factors has on outcome measures 
is  well  recognised  in  epidemiological  research.[15]  Several  outcome  indicators  are 

























usually  not  been  empirically  assessed,  and  often  evidence  on  validity  is  limited  to 
face-validity, established by expert consensus. In other cases, the evidence is limited 
to construct validity based on recommendations in evidence-based guidelines, which 
document a  link between process and outcome as  found e.g.  in  randomized  trials. 











variation.[15, 31, 32] Statisticians therefore often emphasize addressing random variation in 
reporting performance.[30, 33] It remains unclear in the Netherlands to what extent 
random variation influences between-hospital comparisons with commonly used outcome 
indicators and how to deal with this random variation.  
 
Confounding 
The confounding effect that variations in patient factors has on outcome measures is well 
recognised in epidemiological research.[15] Several outcome indicators are based on their 
use in randomised controlled trials as an unfavourable outcome of care. Examples include 
re-admission rates or nosocomial pressure ulcer occurrences. Findings in randomised 
controlled trial populations are not automatically equivalent to the groups of patients 
generally admitted in hospitals.[34-40] Performance indicators do not merely reflect the 
quality of care alone, because variations in case-mix can have a crucial influence on their 
values. For example, in the case of stroke patients, several studies showed that after 
adjustment for prognostic factors, the statistically significant differences in mortality or 
functional outcome between hospitals seen in the crude data became non-significant.[41, 
42]  
The outcome of a performance 
measure can be seen as the sum of 
factors relating to the patient, the 
illness, the treatment and the 
organisation (figure 2), whereas only 
the last two factors relate to quality 
of care that can be influenced by 
professionals or hospital 
management.[9] 
Hence, adjustment for factors relating 






















Figure 2; Conceptual framework of factors 
influencing an outcome[9] 
figure 2; Conceptual framework of factors influencing an outcome[9]











overall aim and research questions
This  thesis  aims  at  evaluating  the  usefulness  of  outcome  indicators  and  process 
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for  to avoid overinterpretation of  the numbers  in  the quest  for more  transparency 
in health care. Adequate sample size is a prerequisite in attempting reliable ranking.






have  been  set  up  to  monitor  the  performance  of  health  care  institutions  using  a 
framework  of  structure,  process  and  outcome  indicators.(1-2)  Public  disclosure  of 
the  results  of  hospital  performance  leads  to  several  inconsistent  comparisons  and 
rankings and there is concern among professionals about the value and reliability of 






pital heterogeneity  (how  large are  the differences between hospitals). The amount 
of uncertainty in the analysis of hospital performance is higher than intuition might 
suggest.(12) For low-incidence outcome and for smaller subgroups in the population 
uncertainty  can be  large.(13)  The  smallest hospitals would  likely  experience five  to 
seven  times more  uncertainty  concerning  their  true  performance.(14)  The  second 
component is heterogeneity between hospitals.(15) Heterogeneity relates to the true 
differences  beyond  chance  between  hospitals  and  can  be  estimated  with  random 
effect models. Both components determine the reliability of ranking with an indica-
tor, the “rankability”. The term rankability was first used by van Houwelingen et al. 
(webpublished  research  (16))  it  measures  what  part  of  the  variation  between  the 

















used  the  data  of  2007, which  are  publicly  available  at  www.ziekenhuizentranspar-
ant.nl. For acute myocardial infarction (AMI), the majority of hospitals reported the 



























































































ρ = τ2 / (τ2 +median σ2)


































































































τ2 0,29  for colorectal  surgery. The corresponding 95% range of  the odds ratios was 
0,35 and 2,86 for colorectal surgery, meaning that hospitals at the higher end of the 
















-  + rankability
Nosocomial Pressure Ulcer prevalence 0,19 0,11 0,52 1,91 37%
Nosocomial Pressure Ulcer incidence 
total hip replacement
0,85 0,16 0,46 2,17 38%
Leakage of the bile duct within 30 days 
after cholecystectomy
1,01 0,00 1 1 0%
Unintended reoperation after 
colorectal surgery
0,12 0,29 0,35 2,86 71%
In hospital mortality after AMI age 
groups combined#
0,19 0,27 0,36 2,76 58%
Readmission after heart failure age 
groups combined#
0,14 0,15 0,47 2,11 51%
Remaining cancer tissue after breast-
saving lumpectomy
0,25 0,28 0,35 2,82 53%
table 3 Rankability. # results for the combined age groups are adjusted for age






the  crude  hospital  effects  is  due  to  true  differences  (as  opposed  to measurement 
error). Combining fixed effect  logistic  regression models and  random effect  logistic 
regression models, we could estimate uncertainty within the individual hospitals and 
the unexplained heterogeneity between hospitals. We  found  considerable  variabil-





in  addition  ignores  the magnitude of  the differences.  E.g. when  the  random effect 
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Random variation and rankability of hospitals using outcome indicators
The measurement  of  rankability  provides  a way  of  assessing  reliability  of  ranking. 
We might compare rankability with the signal-to-noise ratio that is used for electrical 
signals and is defined as the power ratio between a signal (meaningful information) 
and  the background noise  (unwanted  signal).  So,  an  indicator provides  a  signal  on 



















This  raises  questions  about minimal  power  calculations  or  combining  indicators  to 






















A  categorization  for  rankability  is  yet  still  arbitrary.  Lingsma et  al  suggested  that  > 
70% rankability should be fair to rank hospitals.(20) Higgins et al assigned adjectives 
of  low, moderate and high to the  I 2 values of 25%, 50% and 75%.(26)  I 2  is used to 
measure heterogeneity in meta-analyses(27) and is similar in nature to our rankability 




that  take  into account  random variability.(13-15)  This  requires  statistical  knowledge 
and  access  to  advanced  statistical  programs.  No  ranking  attempt  should  be made 
when rankability  is  low.  It might also be  interesting  to  identify subsets of hospitals 
that meet or exceed a standard, fall below a standard, and a subset that cannot be 
classified due to sample size limitations. The random effect estimates with confidence 
intervals  shows  if  a  hospital  significantly  differs  from  the  mean  beyond  statistical 
 
33 
statistical programs. No ranking attempt should be made when rankability is low. It 
might also be interesting to identify subsets of hospitals that meet or exceed a standard, 
fall below a standard, and a subset that cannot be classified due to sample size 
limitations. The random effect estimates with confidence intervals shows if a hospital 
significantly differs from t e mean beyond statistical uncertainty. In that, random effect 
estimates can be used to identify subsets, next to funnel plots as a graphical display of 
these subsets. 
Reliability of ratings depends on sample size and heterogeneity, but also on biases. We 
can draw a conceptual framework t  summarize the elements of bet een hospital 
differences (figure 1).(20)  
 
The observed differences can be divided in unexplained differences and chance. By using 
random effect models chance can be corrected for, leaving patients characteristics, 
registration bias, quality of care and residual confounding as elements of the 
unexplained differences. Consequently, ranking reflects the total of unexplained 
differences between hospitals and not true differences in the quality of care. This is a 
limitation of this study, but the data as publicly reported does not provide any additional 
information.  













using  random  effect models  chance  can  be  corrected  for,  leaving  patients  charac-
teristics,  registration bias,  quality  of  care  and  residual  confounding  as  elements  of 
the unexplained differences. Consequently, ranking reflects the total of unexplained 




ranking hospitals. When  judging hospital quality  the  influence of  random variation 
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The  role of  transparency  in quality of  care  is becoming ever more  important. Vari-
ous indicators are used to assess hospital performance. Judging hospitals using rank 
order takes no account of disturbing factors such as random variation and case-mix 
differences.  The  purpose  of  this  article  is  to  compare  displays  for  the  influence  of 





We  calculated  confidence  intervals  of  the  point  estimate  and  the  simulated  confi-
dence intervals of the ranks with bootstrap sampling. We visualized the influence of 


















Hospitals  face  increasing  demands  with  regards  to  the  quality,  transparency  and 










including  concerns  over  adjustment  for  case-mix  and  the  role  of  chance  in  deter-








Hospitals face increasing demands with regards to the quality, transparency and 
accountability of health care. Since the early 1980s interest in measuring hospital 
performance has led to the development of many performance indicators (PIs). A PI is a 
measurable element of practice performance for which there is evidence or consensus 
that it can be used to assess the quality of care.(1) The purpose of performance 
indicators must balance the need for accountability with the need to promote quality 
improvement initiatives (2), therefore provide the incentive to improve the quality of 
care. 
League tables are often used for displaying hospitals performance (figure 1), suggesting 
a rank order.  
 
Figure 1. League table of the pressure ulcer prevalence in 89 Dutch hospitals in 2005 
League tables provoke concerns among health service providers for several reasons 
including concerns over adjustment for case-mix and the role of chance in determining 
their rank.(3) Because there are no minimal sample size requirements in PI 
measurement, random variation plays an important role in the interpretation of the 
results. In the Netherlands quality of care in hospitals is assessed by the Health Care 
fi  . League table of the pressure ulcer prevalenc  in 89 Dutch hospital  in 2005












For  the  analysis  we  used  the  2005  publicly  available  data  on  three  performance 
indicators; pressure ulcer (PU), cerebro vascular accident (CVA) and acute myocardial 
infarction  (AMI).  The  indicators are  selected  to  reflect  several problems  that occur 










With  the  function  Qbinom  in  S  plus  we  calculated  the  95%  CI  for  the  number  of 
successes obtained  in a number of binomial  trials equal  to  the number of patients 
that was  judged with the observed probability of being a case. These were divided 
again by  the number of  trials  to obtain  a CI  that  reflects  the discrete  character  of 
the  observations.  CI’s  for  the  ranks were  calculated  by  a  parameterized  bootstrap 















errors width.(12) We  calculated  the  confidence  interval  taking  into  account  the 
discrete nature of the numbers. This exact calculation was necessary because the 
number of scores in which y = 0 was high in some indicators.






















For  instance, the prevalence of pressure ulcers  in the first hospital  in figure 2a was 
1.3%, but with a confidence interval ranging from 0 to 9%. The wide range was due to 




mean cases and 
patients
mean outcome* % 
(95% cI) p†
Pressure Ulcer prevalence 89 14/238 6,0 (4,7-7,8) < 0,0001
Ischemic Stroke; 7-day mortality
  patients< 65 year 91 2/63 3,2 (1,6-6,3) < 0,0001
  patients ≥ 65 year 91 10/178 5,6 (4,1-7,7) < 0,0001
Hemorrhagic Stroke; 7-day mortality
  patients< 65 year 90 2/12 16,7 (8,4-30,3) 0,0005
  patients ≥ 65 year 90 9/35 25,7 (19,0-33,8) < 0,0001
Acute myocardial infarction patients ≥ 65 year
  In-hospital mortality 37 16/131 12,2 (9,6-15,4) < 0,0001
  30-day mortality 53 16/146 11,0 (8,6-13,8) < 0,0001
Acute myocardial infarction patients < 65 year
  In-hospital mortality 37 3/102 2,9 (1,7-5,2) 0,06







The forest plot shows, that the point estimates ranged from 1.3 to 19.4% for pressure 
ulcer. The confidence intervals surrounding the point estimates had a wide variation 
(figure 2a).  
 
Figure 2 Three different graphical representations of the pressure ulcer prevalence in the Dutch 
hospitals in 2005. (a) 'Forestplot' with point estimate for each hospital and 95%-CI. The vertical 
line represents the Dutch norm for the pressure ulcer prevalence. (b) 'Funnelplot' in which 
pressure ulcer prevalence is plotted against the population measured in the hospital. The 
horizontal line represents the Dutch norm (5%), the funnel shaped lines are the limits of the 95%-
CI (2xSE) and the 99,8%-CII (3xSE); Hospitals situated outside these limits perform significantly 
different from the norm. (c) ‘Rank plot’ showing the ranks for pressure ulcer prevalence 
compared with the ranking according to the median of the bootstrap replicas and its CI.  
For instance, the prevalence of pressure ulcers in the first hospital in figure 2a was 1.3%, 
but with a confidence interval ranging from 0 to 9%. The wide range was due to the 
small number of patients (74). In contrast, the second hospital listed in this graph, also 
scored 1.3% prevalence, but with confidence intervals of 0.5 and 4%. Despite the equal 












also  scored  1.3% prevalence,  but with  confidence  intervals  of  0.5  and  4%. Despite 
the  equal  results,  the  second  hospital  performed  significantly  better  than  the  na-
tional standard of the Inspectorate, which is 5%.The funnel plot shows the confidence 











Figure 3. Three different graphical representations of the stroke indicator in the Dutch hospitals 
in 2005. (a) 'Forestplot' with point estimate for each hospital and 95%-CI. The vertical line 
represents the average for stroke mortality. (b) 'Funnelplot' in which mortality is plotted against 
the population measured in the hospital. The horizontal line represents the average mortality, 
the funnel shaped lines are the limits of the 95%-CI (2xSE) and the 99,8%-CII (3xSE); Hospitals 
situated outside these limits perform significantly different from the average. (c) ‘Rank plot’ 
showing the ranks for stroke mortality compared with the ranking according to the median of the 
bootstrap replicas and its CI. 
The point estimates of hospital mortality varied, ranging from 0-100% mortality. The 
wide confidence intervals in the forest plot are due to the fact that small numbers of 
patients were admitted to the hospitals in 2005. The first 24 hospitals reported a 
mortality of 0%. However, hospital number 24 admitted only 2 that year, providing a 
confidence interval from 0-100% (figure 3a). The funnel plot shows that apart from 
random variation there were few differences between the hospitals (figure 3b). The rank 
plot reveals wide confidence intervals making the ranking attempt very uncertain (figure 
3c).  
ACUTE MYOCARDIAL INFARCTION  
figure 3. Three different graphical representations of the s roke indicator in the Dutch hospital  in 2005. (a) 

















acute myocardial infarction 
We  illustrate  the  influence  of  random  variation  on  30-day  hospital mortality  after 
AMI in patients younger than 65 years. The point estimates in the forest plot ranged 





ACUTE MYOCARDIAL INFARCTION  
We illustrate the influence of random variation on 30-day hospital mortality after AMI in 
patients younger than 65 years. The point estimates in the forest plot ranged from 0-
9,8%, with different confidence intervals based on patient numbers (figure 4a). Given a 
mean score of 2.5% mortality, only two hospitals performed significantly worse than the 
others. The funnel plot shows that it is hard to distinguish between hospitals that 
performed well and those that performed poorly (figure 4b). No meaningful ranking of 
hospi als could be done on the basis of AMI m rtality (figure 4c). 
 
Figure 4 Three different graphical representations of the AMI mortality in the Dutch hospitals in 
2005. (a) 'Forestplot' with point estimate for each hospital and 95%-CI. The vertical line 
represents the average for AMI mortality. (b) 'Funnelplot' in AMI mortality is plotted against the 
population measured in the hospital. The horizontal line represents the average AMI mortality, 
the funnel shaped lines are the limits of the 95%-CI (2xSE) and the 99,8%-CII (3xSE); Hospitals 
situated outside these limits perform significantly different from the average. (c) ‘Rank plot’ 
showing the ranks for AMI mortality compared with the ranking according to the median of the 
bootstrap replicas and its CI. 
 
figure 4 Three different graphical representations of the AMI mortality  in the Dutch hospitals  in 2005.  (a) 



















forest  plot.(11)  Researchers  often  use  the  funnel  plot  in  meta-analyses  to  display 













In our experience,  the  funnel plot provides a straightforward representation of  the 
differences  between  hospitals.  The  hospitals  situated  outside  the  95%  confidence 






of  other  hospitals  with  the  same  volume  and  subsequently  set  their  own  targets. 
The  funnel plot provides a good overview of  the  relative position of  the  individual 
hospitals. 




of  the  original measures  strongly  influence  the  rank.  This  is  seen  in  the  rank  plot 
which shows that random variation greatly influences the interpretation of what the 
true rank might be. Ranking may even be misleading, since random variation plays 
a dominant  role  for  some  indicators,  such as  stroke and AMI.  The overview of  the 
relative position is limited.
















hospitals  or  hospitals  in  rural  areas.(33)  Correction  for  these  confounding  factors 
with these PI is impossible because the public available data does not include patient 
characteristics. This requires further investigation. In our methodology we used the 
most  common scientific approach  calculating CI  and using  the described plots. We 
did not intensively search for other graphical displays to visualise the data. Also the 
usefulness  of  the different  graphs was not  systematically  assessed.  This  requires  a 
more structural approach.(20)
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We  conclude  that  despite  statistically  significant  differences  between  hospitals, 
random variation  is  a  crucial  factor  that must be  taken  into  account when  judging 
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increasingly popular,  although  case-mix differences between hospitals  and  random 










surgical procedure varying between 0 and  15.1 per  cent.  Statistically  significant dif-




Conclusion; When  comparing  SSI  rates  in  all  operations,  differences  between  hos-















SSIs  can  partly  be  prevented  using  specific  interventions  before,  during  and  after 















The  PREZIES  network  database  (http://www.prezies.nl/zkh/index.html)  was  used. 
PREZIES  is  a  Dutch  initiative  for  the  nationwide  surveillance  of  healthcare-related 
infections, set up in 1996. The PREZIES network is a consortium of participating hos-
pitals and the National  Institute for Health and Environment. The PREZIES  initiative 
aims  to  improve  the  quality  of  care  in  hospitals  by measuring  and  communicating 




to  1  year.  The  data  reflect  SSI  rates  in  elective  procedures  and  emergency  surgery 
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As  a  next  step,  to  account  for  the  differences  in  case mix  between  hospitals,  the 
random-effects models were fitted, including patient and surgery characteristics that 








Rankability  relates  the variance of  the  random-effects τ2  (differences between hos-












surgical  interventions  (Table S1,  supporting  information). The  study population was 






mean.  In  a  limited number of  cases  (less  than 0.1  per  cent),  hospitals  reported  an 
operating time of  less than 10 min.  It  is assumed that these are registration errors, 
but because of their minor impact they were not corrected. The median number of 
patients per hospital varied between the different types of surgery, from 12 for the 
reconstruction  of  abdominal  vessels  to  204  for  hip  replacement.  The  SSI  rate  also 





asa grade (%) Wound grade (%)
≤ II > II unknown 1–2 3–4 unknown
Mastectomy 69 (1–247)† 90 9 1 99 0 1
Laparoscopic 
cholecystectomy
50 (6–382)† 91 6 3 97 2 1
Colonic resection 105 (16–530) 63 32 5 85 14 1
Abdominal vessel 
reconstruction 
163 (14–464) 51 43 6 97 0 3
Hip replacement 72 (3–960)† 87 11 2 100 0 0
Knee replacement  75 (3–920)† 87 12 1 100 0 0
Abdominal hysterectomy 75 (30–233) 94 4 2 99 1 0
Caesarean section 36 (1–209)† 93 1 6 99 0 1














(range)* ssI rate (%)†






1558 12 135 (43–231) 2 (0–9) 1.3
(0–5.1)





























































95% range* of 
centre differences
95% range* of 
centre differences
τ2 P† lower upper τ2 P† lower upper
Mastectomy 0.20 0.046 0.42 2.40 0.16 0.149 0.46 2.18
Laparoscopic 
cholecystectomy
0.22 0.083 0.40 2.50 0.20 0.118 0.42 2.38
Colonic resection 0.62 < 0.001 0.21 4.67 0.58 < 0.001 0.23 4.42
Abdominal vessel 
reconstruction 
0 0.500 1.00 1.00 0 0.472 1.00 1.00
Total hip replacement 0 0.500 1.00 1.00 0 0.496 1.00 1.00
Knee replacement 0.22 0.078 0.4 2.48 0.17 0.128 0.45 2.25
Abdominal hysterectomy‡ 0 0.500 1.00 1.00 0 0.481 1.00 1.00
Caesarean section§ 0.81 0.032 0.17 5.82 1.10 0.024 0.13 7.59









Fig. 2 Effect estimates for differences in overall surgical-site infection (SSI) rate between 34 
hospitals in all surgical procedures combined: first column a fixed-effects unadjusted, second 
column b random-effects unadjusted and third column c random-effects adjusted models. Values 
are logistic regression coefficients, compared with the average outcome. In each plot, hospitals 
on the right side have estimated SSI rates above the average, whereas those on the left have a 
lower than average estimated SSI rate. Dot sizes indicate the number of patients per hospital  
After adjustment for case mix, the differences between hospitals declined further, 
especially for the overall SSI rates (Fig. 2c). The 95 per cent range of centre differences 
declined from 0.20 to 4.91 to 0.42 to 2.33 (Table 3), indicating that part of the 
differences between hospitals in SSI rate could be explained by their case mix. Within 
the specific procedure types case-mix difference explained less of the variation in SSI 
rate (Table 3, Fig. 3). Although the overall differences between hospitals in SSI rates for 
colonic resection and for all types of surgery remained significant, this significance was 
fig. 2 Effect estimates for differences  in overall surgical-site  infection (SSI) rate between 34 hospitals  in all 
surgical  procedures  combined:  first  column  a  fixed-effects  unadjusted,  second  column  b  random-effects 
unadjusted and third column c random-effects adjusted models. Values are logistic regression coefficients, 
compared with the average outco e. In e ch plot, hospitals on the right sid   ave estimated SSI rates above 
the average, whereas those on the left have a lower than average estimated SSI rate. Dot sizes indicate the 
number of patients per hospital 







After  adjustment  for  case mix,  the  differences  between hospitals  declined  further, 











Fig. 3 Effect estimates for differences in surgical-site infection (SSI) rate for colonic resection 
between 16 hospitals: a fixed-effects unadjusted, b random-effects unadjusted and c random-
effects adjusted models. Values are logistic regression coefficients, compared with the average 
outcome. In each plot, hospitals on the right side have estimated SSI rates above the average, 
whereas those on the left have a lower than average estimated SSI rate. Dot sizes indicate the 
number of patients per hospital  
RANKABILITY 
Rankability was calculated for the surgical interventions that showed significant 
differences in the random-effects analysis. For caesarean section, rankability could not 
be calculated because the majority of hospitals reported no SSIs. For the combined SSI 
rates, rankability was 85 per cent without case-mix adjustment, but only 8 per cent after 
case-mix correction. This means that, of the observed case-mix-adjusted differences 
between hospitals, 8 per cent at most may have been due to the quality of prevention of 
SSI; 92 per cent was explained by random variation and case mix. For colonic resection, 
rankability before and after case-mix correction was 80 and 78 per cent respectively, 




















Random  variation  largely  explained  apparent  differences  between  hospitals  in  SSI 
rates  for  individual  surgery  types.  Apparent  differences  between hospitals  in  com-













estimates  very  reliable,  rankability will  be  reasonable. When differences  are  large, 
greater uncertainty can be accepted. 
By  combining  fixed-effects  logistic  regression  models  and  random-effects  logistic 
regression  models,  it  was  possible  to  estimate  uncertainty  within  the  individual 
hospitals  and  the  unexplained  heterogeneity  between  hospitals.  It was  found  that 
ranking hospitals, adjusted random-effect estimates, led to overinterpretation of the 
small  and uncertain differences  in SSI  rates, except  in  colonic  resection. Significant 
differences were found in SSI rates after colonic resection and rankability remained 
good  after  case-mix  correction.  It  is  plausible  that  the  indication  for  surgery,  such 
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as chronic bowel disease,  traumatic  injury or colorectal  cancer, may cause  residual 
confounding  that  explains  part  of  these  significant  differences.  Nevertheless,  the 
















































sive  medication.  This  incomplete  case-mix  correction  may  lead  to  overestimation 
of the differences attributed to quality of care. Registration bias  is probably  limited 
in  this  study.  The  authors believe  the data  to be  reliable  and  comparable because 
they were collected in a voluntary registry. Moreover, the hospitals contribute to the 










compare outcomes between hospitals in the present study; these are useful for 
visualizing the influence of random variation28–30,38,39. Other alternatives for 
benchmarking include comparisons with the best-performing hospitals, a national 
average or a norm17–20, or to compare rates from year to year within the same hospital. 
In this study, SSI rates were adjusted for random variation and case-mix differences 
between hospitals. However, there may be residual confounding caused by incomplete 
case-mix correction and registration bias that explains the remaining differences. In fact, 
only a small part of observed unadjusted differences in SSI rates between hospitals was 
likely to be attributable to quality-of-care differences (Fig. 4)33,40–42.  
 
Fig. 4 Conceptual framework of between-hospital differences.  
The length of the bars in this figure is arbitrary and differs for the various indicators. For 
example, for overall surgical-site infection (SSI) the effect of case mix is large and that of 
uncertainty is small, whereas for colonic resection the effect of uncertainty is large but 
that of case mix is limited. 
With regard to case-mix correction, adjustment was made for relevant and available 
predictors of SSI. In addition, there are unmeasured confounders that may caus  
differences between hospitals in SSI rate. For hip replacement, for example, revisional 
fig. 4 Conceptual framework of between-hospital differences.
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the American  College  of  Surgeons National  Surgical Quality  Improvement  Program 
has  been  collecting  data  on  approximately  40  preoperative  and  20  intraoperative 
variables16,45. Therefore, the present study might have overestimated the quality-of-




The  rankability measure uses  the median  standard error, which  is only  a  summary 
of  the overall uncertainty of  individual hospital estimates. Rankability as presented 
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% surgery types 
1.  561 2,7 (15) 44 15 1,3,5,8,10
2.  612 0,2 (1) 57 17 6,7,8,10
3.  631 1,0 (6) 63 25 6,7,8,10
4.  691 1,3 (9) 69 31 6,7
5.  822 4,3 (35) 69 35 1,4,5,6,7
6.  321 2,5 (8) 31 0 10
7.  255 0,4 (1) 68 38 6,7
8.  68 17,7 (12) 70 49 4
9.  844 3,6 (30) 70 28 1,4,6,7
10.  369 4,1 (15) 72 34 4,6
11.  320 2,2 (7) 70 31 6,7
12.  110 13,6 (15) 71 46 4,5
13.  138 4,4 (6) 59 0 1
14.  329 1,5 (5) 71 23 1,4,5,6,7
15.  268 2,2 (6) 58 0 1
16.  226 2,7(6) 62 26 1,3,4,6,7,8,10
17.  314 2,6 (8) 71 32 4,6,7
18.  606 1,7 (10) 68 34 1,3,4,5,6,7
19.  395 2,3 (9) 44 11 1,3,6,7,8,10
20.  1007 1,0 (10) 61 23 1,3,4,5,6,7,8,10
21.  453 1,8(8) 60 20 1,6,7,10
22.  277 5,8 (16) 46 16 1,3,10
23.  352 3,4 (12) 56 22 1,3,4,10
24.  234 0,9 (2) 35 8 3,8,10
25.  510 2,2 (11) 64 32 6,7
26.  135 8,9 (12) 68 27 1,4,5
27.  318 5,4 (17) 70 32 4,6,7
28.  273 11,0 (30) 69 37 4,5,7
29.  562 1,3 (7) 69 32 6,7
30.  30 10,0 (3) 73 90 5
31.  132 3,0 (4) 51 26 3
32.  322 3,1 (10) 57 21 1,3,6,7,8
33.  663 1,7 (11) 67 33 1,3,4,5,6,7
34.  481 4,4 (21) 65 28 1,3,4,5,6,7,8
Total 13629 2,8% (378) 64 26% all
supplemental table; individual  hospitals  Surgery  types:  1=mastectomy  3=Laparoscopic  cholecystectomy 
4=Colon resection 5=Reconstruction abdominal vessels 6=Hip Replacement 7=Knee replacement 8=Abdomi-
nal hysterectomy 10=Caesarean section
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defined  by  the National  Pressure Ulcer  Advisory  Panel  (NPUAP)  and  the  European 
Pressure Ulcer Advisory panel  (EPUAP)(1).  These ulcers decrease  the quality  of  life 
for patients(2,  3)  and  increase morbidity and mortality(4).  Incontinence associated 
dermatitis (IAD)  is moister related skin breakdown occurring when urine or stool  is 
left in contact with the skin(5-7). 
PU patients  require  intensified nursing  and medical  care,  resulting  in  an  increased 
workload  for  healthcare workers  and  increased  healthcare  costs(8-11).  PU  and  IAD 
can be avoided with adequate measures and preventive care, though not all PU’s are 
avoidable(12-14). During the 2011 Consensus Conference  in Baltimore, Maryland(15) 
avoidable was defined by  the NPAUP as:  “An avoidable pressure ulcer can develop 
when the provider did not do one or more of the following: 
1.  evaluate the individual’s clinical condition and pressure ulcer risk factors; 
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PU occurrence  is widely used as  an  indicator  for  the quality of  care  (16-18).  In  the 




tive care processes  (18,  19). Brandeis et al  found several  risk  factors associate with 





in PU care processes  (22).  In  the  latter prospective  study, nurses  in nursing homes 
observed ten preventive care processes during a 3-day data-collection period, but it 





The aim of  this  study was  to explore  the  relation between the occurrence of pres-
sure ulcers or incontinence dermatitis as an outcome indicator and the quality of the 
preventive care processes.

































































of admission  in the hospital. Risk assessment  is viewed as a first step  in  identifying 
patients for whom prevention should be a part of the care process. 
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The  expert  panel member were  informed  about  of  the  purpose  of  the  study.  The 
audit  expert panel discussed  the  interpretation of  the guidelines during a meeting 


































This  first  assessment was  done  individually  by  the  experts without  information on 
the assessments of their team members. In the first evaluation, the team members 

































Study size;  For  the  case-control  study,  we  performed  a  power  analysis  using  the 
bootstrap method. We simulated datasets with 44 cases (a number that was already 
known), each with two controls. The main predictor was quality of care in four cat-








tile  range  in  case of non-parametric  variables. Ordinal  and nominal  variables were 










was expected and  tested between  the  risk  score and care needs at admission, age 
and gender. We calculated agreement between the different experts within the teams 
using a weighted Kappa analysis in Medcalc vesion 11.6. 
Matching procedure;  For every  case,  two controls were  selected matching on  type 
of  nursing  unit  and  length  of  stay,  expecting  these  factors  to  be  confounders,  and 

















The  audit  teams,  blinded  for  outcome,  provided  132  assessments  of  patients.  The 
assessments of the nine criteria (Figure 2) showed differences between the cases and 
the  controls  for  risk  assessment,  prevention of  heel  PU  and  the use of  alternating 
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risk	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   pa9ent	  informa9on	   reposi9oning	   heel	  preven9on	   alterna9ng	  
ma?ressess	  
incon9nence	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   skin	  assessment	   non-­‐
recommended	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no	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   major	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figure 2: assessment of the individual care processes; differences between cases and controls. The raw num-
ber of patients are listed per category within the bars.


















cases	  (n=44)	   controls	  (n=88)	  
op:mal	  care	   subop:mal	  care	  1	   subop:mal	  care	  2	   subop:mal	  care	  3	  
figure 3: quality score distribution between cases and controls. The raw number of patients are listed per 
category within the bars.







with  PU/IAD were  the  factors  quality  score,  PU  risk  score,  age,  care  needs  before 












variable or cI p-value or cI p-value
Quality score 2.0 1.3-3.0 0.001 1.9 1.1-3.3 0.032
PU risk score 1.3 1.2-1.5 <0.001 1.3 1.0-1.4 0.018
Type of Illness, malignancy 3.3 1.2-9.3 0.024 4.3 0.9-20.1 0.067
Care needs before admission 2.6 1.2-5.6 0.014 2.3 0.7-7.1 0.153
Number of care problems 1.6 1.2-2.1 0.003 1.2 0.8-1.8 0.338
Age per decade  1.6 1.2-2.0 0.001 1.2 0.8-1.7 0.511
ICU admission during hospital stay 3.9 1.4-11.0 0.011 1.4 0.3-6.7 0.708
Gender 1.9 0.9-4.0 0.089
Ethnicity (autochthonous/immigrant) 0.5 0.2-1.5 0.213
Living with partner 1.2 0.5-2.5 0.694
table 2 Logistic regression analysis. ADL-activities of daily living, PU- pressure Ulcer, ICU, intensive care unit





The aim of  this  study was  to explore  the  relation between the occurrence of pres-
sure  ulcers  or  incontinence  dermatitis  as  an  outcome  indicator  and  the  quality  of 


































and  important  for  inquiries  into  the major  factors  contributing  to  the  sub-optimal 







































explanatory  studies  (54,  55).  Our  study  illustrates  the  potential  usefulness  of  this 
design for studies of process-outcome relationships in nursing care.




Limitations  of  the  study  were  found  in  underreporting  of  preventive  measures  in 













In  the parent  study,  true  cases of  category  1 PU might have been missed, because 
they were overlooked by nurses  in  the  initial assessment.(56-58) This misclassifica-
tion could have influenced the control group, making the difference more difficult to 
prove. 


























Participation of  authors;  JPM and EWS had  the original  idea  for  the  study and de-
veloped  the  study design. AMvD gathered  the data, wrote  the patient  reports and 










hospital-acquired  skin  lesions  in  adult  hospital  patients.  This  finding  indicates  that 
variation in pressure ulcer prevalence reflects variation in quality of care. 










•	 We  found  a  significant  association  between  pressure  ulcer  prevalence  and  the 
quality of preventive care, indicating that the performance indicator does reflect 
the quality of nursing care.
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In  case  of  clearly  defined  health  problems,  it  is  possible  to  quantify  the  extent  of 
the problem using  the data at  the  Inspectorate or  from external data and time se-
ries analysis. Establishing a causal  relation between supervision and observed time 
trends, however,  requires an experimental  research design,  including a prospective 
randomized or a stepped wedge design. 





Inspectorate  (Inspectie voor de Gezondheidszorg,  IGZ)  sooner or  later,  since  the  In-
spectorate keeps a critical eye on the activities of all care providers. The IGZ has also 
been subjecting its own activities to an increasing level of critical scrutiny in recent 




The  IGZ  started  a  surveillance  evaluation  programme  in  2008.  The  aim  of  this 








dicator  database,  the  IGZ  has 
the  part  of  data  it  needs  for 
evaluation purposes in-house.
The  objective  of  the  pres-
ent  study  was  to  investigate 
the  possibility  of  using  the 
Inspectorate’s  own  data  as  a 
basis  for  surveillance  impact 
measurements. Two questions 












Each healthcare professional in the Netherlands comes across the Dutch Healthcare 
Inspectorate (Inspectie voor de Gezondheidszorg, IGZ) sooner or later, since the Inspectorate 
keeps a critical eye on the activities of all care providers. The IGZ has also been subjecting its 
own activities to an increasing level of critical scrutiny in re nt years. This is necessary 
because the social importance of surveillance is increasing, due among other things to the 
effect of the market in healthcare and the increasing need for transparency. These trends 
have led to a greater need for insights into the effectiveness of surveillance, both within the 
Inspectorate and externally.1 
The IGZ started a surveillance evaluation programme in 2008. The aim of this programme is 
“to evaluate and imp ove the methods and instruments (see box on “Surveillance 
instruments”) used for the purposes of surveillance, and to document the contribution 
surveillance makes to the safety and 
quality of healthcare”.2 Data on the 
re ults of interventions befor  and 
after surveillance can be used to 
measure the impact of the 
surveillance. Thanks to the 
improvement of the data collection 
methods used by the IGZ, such as 
redesign of the reports registration 
system or the performance indicator 
dat bas , the IGZ has the part of 
data it needs for evaluation purposes 
in-house. 
The objective of the present study was to investigate the possibility of using the 
Inspectorate’s own data as a basis for surveillance impact measurements. Two questions 
may be distinguished in this connecti : 
Surveillance instruments 
Incident surveillance (IS) deals with the reporting of incidents and 
calamities in practice. The relevant data sources are individual incident 
reports and the Incident Surveillance reporting system. 
Themed surveillance (TS) deals with high-risk aspects or areas within 
the healthcare field. The relevant data come from reports and 
databases from a selection of the institutions involved. 
Risk-indicator surveillance (RS) is periodic surveillance of the risks and 
quality of the care provided in healthcare institutions on the basis of 
performance indicators (PI). The data in question are derived from 
reports and databases from all healthcare institutions covered by the 
surveillance. 






To  investigate  the  first  question mentioned  above, we  determined whether  it was 
possible  to  measure  the  extent  of  the  three  health  problems  in  question  in  the 
Netherlands with the aid of  IGZ data. We estimated the extent of possible over- or 
underreporting by comparison with external data. We looked for information on the 






































curring  in  the Netherlands,  including  those  outside mental  healthcare  institutions. 
The Statistics Netherlands data  show an annual  total of about  1550 suicides  in  the 
Netherlands. This number is larger than the number of suicides reported to the IGZ 
(Fig. 1a), since the Inspectorate only receives reports of suicides occurring in a mental 









the  obligation  to  report  suicides was  introduced.  Statistics  Netherlands  does  have 
data on suicides from before 1984, however.7 This shows that the annual number of 
suicides in the Netherlands had been rising since the 1950s, flattened off around the 














The  prevalence  of  pressure  ulcers  in Dutch  hospitals was  9.8%  in  2003,  according 
to the first IGZ report on this indicator.9 This figure had fallen to 3.8% by 2007.10 The 




The national  average prevalence of  nosocomial  pressure ulcers  in  the Netherlands 













Figure 1 (a) Annual number of suicides in the Netherlands, according to the data of Statistics 
Netherlands ( ) and the IGZ ( ); only suicides occurring in mental healthcare institutions 
are reported to the IGZ. (b) Number of suicides per 100,000 head of population ( ) in the 
Netherlands in the period 1970-2011, according to the data of Statistics Netherlands. 
Mental healthcare institutions are obliged not only to report all cases of suicide to the IGZ 
but also to give full details of each case together with an analysis of the incident and 
suggestions for avoiding such incidents in the future that could be included in a suicide 
prevention policy. The impact of the obligation to report suicides could not be measured on 
the basis of the IGZ data alone since they only date back to 1984, when the obligation to 
report suicides was introduced. Statistics Netherlands does have data on suicides from 
before 1984, however.7 This shows that the annual number of suicides in the Netherlands 
had been rising since the 1950s, flattened off around the mid-1980s and has remained fairly 
stable since then (see Fig. 1b). A similar trend is also observed in other European countries.8 
PRESSURE ULCERS 
The prevalence of pressure ulcers in Dutch hospitals was 9.8% in 2003, according to the first 
IGZ report on this indicator.9 This figure had fallen to 3.8% by 2007.10 The University of 
Maastricht has also been collecting pressure ulcer data since 1998, through the programme 
National Prevalence Measurements on Healthcare Problems (Landelijke Prevalentiemeting 
Zorgproblemen, LPZ). Hospitals throughout the Netherlands participate in this programme 
on a voluntary basis.11 
The national average prevalence of nosocomial pressure ulcers in the Netherlands was 
about 7.5% up to 2004, with a slight tendency to fall that was enhanced after introduction 













The  most  important  source  of  information  on  medication  errors  is  the  “Hospital 
admissions  related  to  medication”  (HARM)  study.18  This  study  estimates  the  pro-











Figure 2 Comparison of data on the prevalence of pressure ulcers in the Netherlands from two data 
sources: the National Prevalence Measurements on Healthcare Problems programme (Landelijke 
Prevalentiemeting Zorgproblemen, LPZ), all healthcare institutions ( ) and only hospitals (
); and the IGZ hospital performance indicators data set ( ). 
The prevalence of pressure ulcers has fallen (3.7% in 2008) since this condition has been 
included in the IGZ basic set of hospital performance indicators in 2003.12,13 However, this 
intervention by the IGZ was not the only measure t at could have educed the prevalence of 
pressure ulcers. Other nationwide initiatives that were introduced, such as the “Get better 
quicker” (Sneller Beter) project, also led to an improvement in the situation.14, 15 
 
MEDICATION ERRORS 
“Medication errors” is the term covering all mistakes healthcare professionals can make in 
connection with medication.16 They an occur at all stages of the medica ion process, from 
prescription through preparation and delivery to administration.17 There is no uniform 
definition of medication errors, and the quality of the data collected on this point is not 
good enough to permit good interpretation. 
The most important source of information on medication errors is the “Hospital admissions 
related to medication” (HARM) study.18 This study estimates the proportion of medication-
figure 2 Comparison of data on the prevalence of pressure ulcers in the Netherlands from two data sources: 
the National Prevalence Measurements on Healthcare Problems programme (Landelijke Prevalentiemeting 
Zorgproblemen, LPZ), all healthcare  institutions ( ) and only hospitals  ( ); and the 
IGZ hospital performance indicators data set ( ).















investigated were  due  to  IGZ  intervention.  It  is  conceivable,  for  example,  that  the 
obligation on mental healthcare institutions to report to the IGZ suicides among their 











measuring the impact of surveillance
As Table 2  shows, quantification of  the  impact of  surveillance by  the  IGZ  is not di-
rectly possible with the aid of existing data sources. The Inspectorate does regularly 
highlight health problems, which causes other actors in the healthcare field to deploy 
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Transparency: can the effect of governmental surveillance be quantified?
























































by  the  IGZ  for  the  purposes  of  surveillance.  The  IGZ  uses  various methods  and  activities  to  perform  this 
surveillance.  The  “products”  shown as  the next  link  in  the  chain are  the  results of  these activities.  These 
















comparison with the literature
This  feasibility  study  is  unique  in  its  kind.  No  previous  attempts  have  been made 
to quantify  the  impact of  government  surveillance. Previous  studies have however 
shown that it is possible to quantify the effect on compliance behaviour. For example, 
the sale of  tobacco  to minors can be  reduced by providing  information to  retailers 
found guilty of  illegal sales or by fining them.21 These authors found that fining the 

















basis  of  IGZ  data.  The  situation was  further  complicated  by  the  fact  that  external 
sources made use of different definitions of medication errors.
We  use  an  interrupted  time  series  design  in  the  present  study.  This  allows  trends 
around the time of an intervention to be analysed. In principle, the IGZ can apply this 
time series approach to its own data. If however the data set used by the IGZ forms 





Implications for further research and policy
An experimental approach in study design is an alternative to the use of time series 





the  IGZ  to  use  a  prospective 
randomised trial for the evalu-
ation of surveillance. However, 
a  randomised  trial  approach 
can have an undesirable effect 
on  surveillance  strategy  since 
it  can  require  one  institution 
to be under surveillance while 
another  is  not.  Phased  intro-
duction  of  surveillance,  for 
example  on  a  regional  basis, 
might  provide  a  solution  to 
this  problem.  The  “stepped 
wedge” approach  (see box)  is 
one  form  of  this  design  that 














LIMITATIONS OF THIS STUDY 
The retrospective nature of the present study limits the conclusions that may be drawn 
from it. Data collected at different moments in time need to be uniform. Changes in the 
definition of an indicator make comparison between different times unreliable. For 
example, the IGZ added “lesion due to incontinence” to the indicators for stage 2-4 pressure 
ulcers in 2008. As a result, data collected after 2008 can no longer be compared with those 
from an earlier date. It was found that medication errors were not defined clearly enough to 
permit estimation of the scope of the problem on the basis of IGZ data. The situation was 
further complicated by the fact that external sources made use of different definitions of 
medication errors. 
We use an interrupted time series design in the present study. This allows trends around the 
time of an intervention to be analysed. In principle, the IGZ can apply this time series 
approach to its own data. If however the data set used by the IGZ forms part of the 
intervention under investigation, external data on the extent of the health problem before 
the IGZ intervention are also required. 
IMPLICATIONS FOR 
FURTHER RESEARCH AND 
POLICY 
An experimental approach in study 
design is an alternative to the use of time 
series analysis. Randomised controlled 
trials are the gold standard for the 
evaluation of interventions, since it can 
be assumed in such cases that any 
external effects are the same for both 
groups so that any health differences 
found can be ascribed to the 
intervention. The Health Council of the 
Research methods 
Interrupted time series (ITS) design  
ITS is a quasi-experimental investigative design in which a group 
of participants are repeatedly tested both before and after a 
manipulation or a natural event. The repeated measurements 
make it possible to observe a trend in the results.  
Stepped wedge design 
Stepped wedge design is an experimental design in which the 
intervention in question is gradually extended over for example a 
number of regions or GP practices. It involves sequential roll-out 
of the intervention to participants (individuals or clusters) over a 
number of time periods. By the end of the study, all participants 
will have received the intervention, though the order in which 
they receive it is determined at random. They act as controls 
while waiting to receive the intervention. 








collection and  the  interventions must be designed  to provide an effective basis  for 
studies.
A prospective randomised trial or a stepped wedge design is one alternative approach 
that  should be  taken  into consideration  for measurement of  the  impact of  surveil-
lance activities.









•	 It  is  difficult  to  quantify  the  exact  contribution  to  these  improvements without 
extensive information on external effects and autonomous developments.













  6  Huisman A, Robben PB, Kerkhof AJ. An examination of  the Dutch Health Care  Inspectorate’s  su-
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2012. We used an  interrupted time  series design  to  study explanations  for  a  trend 
in time between emergency  room entry  and  treatment with  thrombolytic  therapy, 
analyzed by means of segmented regression.
Results;  Between  2006  and  2012,  1703  patients  were  admitted  with  an  ischemic 



















pathway  is often measured by means of  the time  from entrance  in  the emergency 
department (ED), until the patient receives intravenous rtPA: the door-to-needle time 
(DNT).  Intra-organizational  barriers  to timely  thrombolysis  relate  to  the  availability 





wide  protocol  since  2001.  The  neurology  department  implemented  several  quality 
initiatives  to  improve  the care  for acute  stroke patients, especially  focusing on  the 
percentage of patients  receiving  thrombolysis.(6, 7)  Improving door-to-needle time 





























(the  “Erasmus  Stroke  Study”)  and  for  the  reporting  of  the  performance  indicator 
“timely  thrombolysis”  in  ischemic  stroke  patients.  All  patients  with  acute  stroke 











measurement  in  2006  and  tested  for  changes  in  dependent  variable  pre  and post 
intervention with a segmented regression analysis. We considered 2 models. The first 
model was:  log(dtn)=α + βTT. The second model was:  log(dtn)=α + βTT + ∑1-5  [βiIi] + 
∑1-5 [βi*TIT*T], where T (time) represents the time form the start of the measurement 
period (continuous variable, months starting at 1), and βT expresses the overall trend 
before  the  interventions.  I  (intervention)  represents  the difference  in pre and post 
intervention  i,  coded  0  prior  to  the  intervention,  1  post  intervention,  βi  expresses 
the  drop  in  DNT  immediately  after  an  intervention,  and  βi*T  expresses  the  change 
in trend over time. Both models were fitted with and without inclusion of potential 
confounders (age and sex). The estimate (eβ-1)*100 represents the percentage change 
in DNT. The confidence  interval was calculated as  100*(eβ±(1.96*se)-1), where se  is 










referral  from another hospital  for  intra-arterial  thrombolysis, 3 patients because of 









for ischemic stroke 
n
thrombolysis after 







2006 262 12 (5) 60 (14.9) 6 (50) 75 (70-100)
2007 266 13 (5) 60 (17.2) 8 (62) 65 (45-85)
2008 200 31 (16) 67 (16.5) 15 (48) 60 (42-90)
2009 232 45 (19) 62 (17.4) 25 (56) 50 (36-72)
2010 235 54 (23) 62 (16.1) 27 (51) 40 (27-68)
2011 242 49 (20) 65 (14.7) 26 (53) 40 (25-55)
2012 261 58 (22) 63 (15.8) 29 (50) 35 (23-56)
Total 1703 262 63 (16.1) 136 (52) 45 (30-70)
table 1; Demographic characteristics. *Age and gender are related to the rtPA patients 
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Figure 1; Percentage of patients with acute ischemic stroke treated with thrombolysis (red/green 
bars) and the fraction treated within one hour (green) per year from 2006 to 2012. 
In a logistic regression analysis this trend was significant (OR 1.6 per year CI 1.4-1.8). Since 
2006, the median door-to-needle time was reduced from 75 minutes to 45 minutes in 2012 
(p<.001 in a linear regression model). In this period a 12% annual decrease in door-to-
needle time was achieved (CI 16%-8%). We could not find a significant association between 
any specific intervention (figure 2) and the trend in the DNT.  
figure 1; Percentage of patients with acute ischemic stroke treated with thrombolysis (red/green bars) and 
the fraction treated within one hour (green) per year from 2006 to 2012.




Since  2006,  the median  door-to-needle  time was  reduced  from  75 minutes  to  45 






and 2012.  The percentage of  patients  treated within 60 minutes  increased  from 0 
to 81%. Although DNT improved significantly, we could attribute this trend to one or 
more specific interventions. 
We  note  that  all  implemented  interventions  have  been  proven  effective  in  the  lit-
erature.(3, 5, 10-17) An explanation for the lack of significance in our analysis may lie 
in a slow and gradual effect of our  interventions. We selected only those  interven-





We found that median DNT was successfully reduced by 30 minutes between 2006 and 
2012. The percentage of patients treated within 60 minutes increased from 0 to 81%. 
Although DNT improved significantly, we could attribute this trend to one or more specific 
interventions.  
We note that all implemented interventions have been proven effective in the literature.(3, 
5, 10-17) An explanation for the lack of significance in our analysis may lie in a slow and 
gradual effect of our interventions. We selected only those interventions with a fixed 
starting point in time to include in our analysis. Other initiatives, such as discussing DNT for 
every patient at the morning report, could also explain the reduction in DNT (residual 
confounding). We hypothesize that the cumulative effect of various interventions lowered 
the DNT. e constant and increasing focus on improveme t will have steered the 
perception of urgency a ong physicians and ED personnel. Such a perception may translate 
in faster action to initiate treatment.(5) This highlights the complexity of quality 
figure 2; Scatter plot with  regression  lines  indicating effects of  interventions aimed at  improving door-to-
needle time for acute ischemic stroke treatment with rtPA.
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Measuring quality improvement in acute ischemic stroke care; interrupted time series analysis of door-to-needle time
such as discussing DNT  for every patient at  the morning  report,  could also explain 
the  reduction  in  DNT  (residual  confounding). We  hypothesize  that  the  cumulative 































power) or by a true absence.  It remains unclear  if the performance indicator  is not 
suitable  for  explaining  the  individual  interventions  (type  2  error  or  lack  of  power) 
in the single centre setting or if the intervention itself did not have a major impact. 
Furthermore, we  did  not  focus  on measuring more  specific  parts  of  the  care  pro-
cesses,  like  “onset  to  door  time”,  “door-to-CT  time”  or  “door-to-neurologist  time”, 
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lence over a 2-year period. The aim of  this  research was measuring  the effect of a 
trainings program improving knowledge towards pressure ulcer prevention using the 
outcome (pressure ulcer prevalence) combined with several process indicators.
methods; design;  quasi-experimental  interrupted time  series  design. We used  the 
outcome indicator, pressure ulcer prevalence, and several process indicators in a time 
series design  in  two surgical wards  to monitor  the effect of a quality  improvement 






results; We performed eight prevalence measures  in which 299 patients  (120 pre-





conclusion; The  process  indicators  provide  insight  in  the  daily  practice  and  offer 
opportunities  for  further  improvement  of  process  quality.  The  outcome  measure 
presents only an indication of the quality of the preventive care process.




A basic purpose of measuring quality  is  to  improve health  care.  Performance  indi-






planning and  implementation of preventive actions and  the  systematic  registration 
and communication of the effects of these actions [4]. The quality of these processes 







individual measurements  are  largely  influenced by  random variation,  the historical 
data provides trend information on pressure ulcers prevalence. A quality project was 
carried out after an increase of the pressure ulcers prevalence on two surgical units 










The  patient  characteristic’s  and  disease  or  treatment  factors  determine  the  non-
modifiable factors influencing the risk of pressure ulcer development. Combined with 
immobility  and  /  or  limited mobility  they provide  the  extent  of  the pressure ulcer 
risk and the need for prevention. Optimal prevention is essential in avoiding pressure 
ulcers. The knowledge and attitude of caregivers affect the assessment of the risks to 








The  population  consisted  of  all  consecutive  patients with  admitted  at  two  surgical 
units  on  the  days  that  the  prevalence  measurements  took  place.  On  these  two 






We  chose  an  interrupted  time  series  design with  serial  prevalence measurements 
of  pressure ulcers  and process measurements  before  and  after  a  training program 
for  nurses.  Interrupted  time  series  is  a  quasi-experimental  design  to  evaluate  lon-
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variable total n=299 Pre n=121 Post n=178 p-value
Age, mean (SD) 60(14) 53(17) 56(17) 0.18
Gender, male n (%) 182(61) 69(58) 113(63) 0.33
Increased PU risk 201(67) 71(59) 130(73) 0.15
Length of stay, mean (SD) 13(16) 14(19) 11(14) 0.13
Disease n (%) 0.04
oesophagus and stomach 38 (13) 14 (12) 24 (13)
small intestine 22 (7) 11 (9) 11 (6)
colon 42 (14) 9 (7) 33 (19)
liver and gallbladder 34 (11) 22 (18) 12 (7)
pancreas 25 (8) 9 (7) 16 (9)
trauma 71 (24) 28 (23) 43 (24)
multi-trauma 27 (9) 11 (9) 16 (9)
endocrine system 1 (0.3) 1 (1) 0 (0)
bones and joints (no trauma) 8 (3) 5 (4) 3 (2)
inguinal, umbilical, incisional hernia 13 (4) 6 (5) 7 (4)
renal diseases 1 (0.3) 0 (0) 1 (1)
skin and soft tissue 1 (0.3) 0 (0) 1 (1)
chronic pain syndrome 8 (3) 2 (2) 6 (3)
other 8 (2) 3 (2) 5 (3)
Malignancy n (%) 90.(30) 41.(34) 49 (27) 0.21
Treatment n (%) 0.94
surgery for primary disease 160 (54) 63.(53) 97.(54)
surgery for complications or reconstruction 58 (19) 25.(21) 33.(18)
drain of stent 27 (9) 12.(10) 15.(8)
“wait and see” 20 (67) 8 (7) 12.(7)
other 34 (11) 12.(10) 22.(12)









Pressure ulcers before unit admission n (%) 21 (7,0) 7 (5,8) 14 (7,8) 0.49
Nosocomial pressure ulcers 0.16
Pressure ulcer cat 1 n (%) 28 (9,4) 16 (13,3) 12 (6,7)
Pressure ulcer cat. 2 n (%) 29 (9,7) 11 (9,2) 18 (10,1)
Pressure ulcer cat. 3 n (%) 4 (1,3) 3 (2,5) 1 (<1)
Pressure ulcer cat. 4 n (%) 1 (<1) 0 (<1) 1 (<1)
table 2; pressure ulcer occurrence during prevalence measures























PU cat. 2-4 0.2 (0.51) -5.0 (0.15) 0,4 (0.51)
Risk assessment -0.7 (0.03) 8.4 (<0.01) 0.8 (0.09)
Patient information 0.3 (0.65) 4.0 (0.41) 0.4 (0.51)
Alternating mattresses -0.4 (0.2) 3.8 (0.26) 0.5 (0.30)
Heel prevention 0.1 (0.83) -0.2 (0.96) -0,1 (0.76)





one patients had pressure ulcers on admission at the Erasmus MC or developed pressure 
ulcers on another unit in the Erasmus MC during the hospitalization and were excluded. 
Twenty-two patients developed pressure ulcers category 2-4 on the units during the project 
period. The outcome measures are pres nted in t ble 2 and figure 2.  
 
Figure 2; PU prevalence before and after an intervention aiming at improving the knowledge on 
pressure ulcer prevention among nursing staff of two surgical units. 
The trend prior to the intervention varies between 5 and 14%. After the training, we 
observe a drop in pressure ulcer prevalence to 3 and 0%, which is a clinically relevant effect. 
This effect is long lasting, since in the last two measurements, the prevalence rises again to 
15%. In segme ted logistic regression analysis, this outcome was not statistically significant 
due to the small numbers (Table 3). 
The graphical display of the process measures (figure 3) shows that particularly in risk 
assessment we were able to improve the quality of care, which remained stable over the 



























by  an  increasing  trend  (Table  2).  Patient  information,  heel  prevention  and  reposi-


















































% heel prevention in risk patients
figure 3 Process indicators before and after the intervention




assess. Thus  it  is unclear what contributed  to  these non-significant  results. We did 
achieve a significant improvement in the process indicator risk assessment, measured 





















Generalizability  to quality  improvements  is  limited  for only  two surgical wards  in a 
specific setting were included in this quality project. Generalizability to other indica-
tors however, is valid in case of small number. Despite these limitations, the findings 
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Although  Florence Nightingale  had  high  expectations  of  the  possibilities  of  perfor-
mance indicators (“hospital statistics”) it took more than a century before her ideas 
were carried out on a large scale with the purpose of “enabling us to ascertain the 
mortality in different hospitals, as well as from different diseases and in different dis-
tricts of the same country”[1]. This goal has now largely been met, thanks to extensive 
efforts of data collection. However, we are still far from her ideal that performance in-
dicators will “improve the treatment and management of the sick and maimed poor”. 












Furthermore, the graphical displays  in which  indicators are presented must  include 
information on random variation. The  funnel plot provided a  representation of dif-















both  random  variation  and  case-mix  must  be  addressed  systematically  in  perfor-
mance measurement before conclusions can be drawn on the quality of hospital care 
(chapter 4). 
2. “How strong is the relation between outcome indicators and the underlying care 
processes, and can the performance indicator be used for quality improvement?”
Exploring the process-outcome relation, we found that the outcome indicator ‘pres-
sure ulcer occurrence’ reflected differences in the quality of the bundle of preventive 
































Of  all  available  hospital  indicators,  we  selected  in  our  research  only  a  limited 




















Care  Inspectorate’s  indicators  (chapter  2  and  chapter  3),  the  data  did  not  include 
case-mix variables. Thus, we were unable to explore the influence of case-mix in these 
outcome measures, while case-mix differences  likely  impact on the comparisons of 
the  individual  hospitals.  This  limitation  in  the  data  restricts  interpretations  of  the 
Dutch Health Care Inspectorate’s indicators, in addition to the statistical uncertainty 










In  consequence,  the  statistically  significant  differences  that we  found  in  almost  all 
indicators  comparing hospitals  cannot be attributed with confidence  to  the quality 
of  delivered  care.  Therefore, we might  have  overestimated  or  underestimated  the 
quality-of-care effects.
In our quality  improvement research, we used a time series analysis, a well-known 








The  use  of  performance  indicators  has  become  popular  in  the  last  decades  based 








Inspectorate did  not  give  a  trustworthy picture of  the quality  differences between 
hospitals due to inherent random variation. This unreliability is caused by small sample 
sizes and/or rare event rates[9]. Other researchers also found that inadequate sample 
sizes were  influencing  the  reliable  assessment  of  performance when  performance 
was  assessed  in  specific  patient  subpopulations.[10,  11]  Methodological  research 
confirmed  that  uncertainty  affects  hospitals with  small  numbers  the most, making 
it difficult to distinguish between hospitals that are performing well and those doing 
badly.[12, 13] The hospital estimates are too extreme (either too good or too poor) 
and  shift  towards  the mean  in  the  random-effects  analysis.  The outcome measure 
for performance evaluation is often the same as used in clinical trials. In these trials, 
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Our  research showed that none of  the  tested  indicators are suitable  for  ranking of 
hospitals.[9, 18, 19] Using the rankability concept to evaluate the reliability of rank-
ing hospitals on mortality after colorectal surgery, research showed that only 38% of 













described  the  usefulness  of  this  plot  [24-28],  although  some  commented  on  their 
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limitations  in reports on standardized mortality ratios (SMRs).  [29] Funnel plots  for 
SMRs  should  be  used with  caution  either when  the  expected number  of  events  is 
































improvement  of  the  quality  of  care,  so  called  “actionability”.  For  this  purpose, we 
investigated two quality improvement projects. In our pressure ulcers quality project, 
we measured both process and outcome variables and the intervention significantly 
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improved  the  pressure  ulcer  risk  assessment  in  surgical  patients.[46]  Despite  the 
fact  that  the  pressure  ulcers  prevalence  decreased  from  14%  to  3%,  this  was  not 
statistically significant. In stroke patients, we demonstrated an improvement in door-
to-needle time, but  could not  relate  this finding  to any of  the  structural or  logistic 
interventions. The process measure improved steadily, but it was unclear to exactly 
what improvement this could be contributed.[47] For internal quality improvement, 
process  indicators  seem  to  be more  informative  than  outcome  indicators.[42,  47] 
More research  is needed on the use of process  indicators, outcome  indicators or a 
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places constrains on  the  interpretability of  the outcomes. The aim of  this  research 
was  to  study  the value of performance  indicators  in  comparing  the quality of  care 




using  the  outcome  indicators  of  the  Dutch  Health  Care  Inspectorate.  Using  the 
concept of  rankability we found that  in  the ranking of hospitals, both the between 
















For  surgical  site  infections, we  found  that  the apparent differences between Dutch 
hospitals in this specific outcome indicator were predominantly attributable to random 
variation and case-mix. This case study provided a clear illustration that both random 
variation and  case-mix must be addressed  systematically  in performance measure-









care  processes  provided  by  nurses.  This  significant  relation  between  outcome  and 
process in pressure ulcer care, supports the usefulness of this indicator in assessing 
the  quality  of  nursing  care. We  confirmed  that  the  pressure  ulcer  prevalence was 
also determined by several patient factors that cannot be influenced (chapter 5). Ad-










always  confirmed  in  research. We  recommend,  that  the  process-outcome  relation 
should be addressed and explored in existing indicators as well as in the development 
of new quality indicators. 
measurIng ImProvement of tHe QualItY of care
In  a  process measure  of  acute  stroke  care, we  found  a  significant  improvement  in 
“door-to-needle  time”  (DNT)  over  recent  years. We  could  not  attribute  this  trend 
to  one  or more  specific  interventions. We  hypothesised  that  the  combined  effect 
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ziekenhuizen,  beïnvloedt  de  onzekerheid  van  de  rangordening.  Derhalve  kan  geen 
van de onderzochte prestatie-indicatoren worden gebruikt voor de rangordening van 
ziekenhuizen. Lage aantallen in de noemer van de indicator (steekproef) en/of weinig 




We  onderzochten  in  hoeverre  de  grafische  weergave  van  de  indicatoruitkomsten 
inzicht gaf  in deze  toevalsvariatie. Daarbij bleek een “forrest plot”  inzicht  te geven 
in  de  ziekenhuizen  die  aanzienlijk  afweken  van  het  gemiddelde.  De  “funnel  plot” 
gaf een visuele weergave van de verschillen tussen ziekenhuizen en een eenvoudige 
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(hoofdstuk  3).  Hoewel meer  onderzoek  nodig  is  naar  de  gewenste  grafische weer-
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Hague,  1956)  studied  Health  Science  at  the  University 
Utrecht  and  graduated  in  2005  on  the reliable assess-
ment of sedation level in routine clinical practice by 
adding an instruction to the Ramsay Scale.  In  addition 
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o  Follow-up studies and case control studies 2006 4,3
o  Methodological topics in Epidemiologic research 2006 1,4
Data-analysis
o  Classical methods CC02  2007 5,7
o  Modern Statistical Methods (EP03) 2007 4,3
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This thesis addresses two major topics in measuring, comparing and 
improving quality of care. We found considerable influence of random 
variation and case-mix in comparing hospitals using performance indicators. 
Although we found a significant relation between outcome and care 
processes, chance variation is the major limitation for the interpretability of 
indicators used for quality measurement or quality improvement. Like a one 
hand clock, we roughly know what time it is.
